Seattle Genetics Inc
Score: Neutral (57)
14 days at current score.
Upgraded from Negative on June 24th 2018
- This company ranked neutral in 3 IHS Markit Categories and the Healthcare sector
- Bearish sentiment is moderate
Short interest | Neutral
Short interest is moderate for SGEN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
ETF/Index ownership | Neutral
ETF activity is neutral. The net inflows of $3.67 billion over the last one-month into ETFs that hold SGEN are not among the highest of the last year and have been slowing.
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is very weak relative to the trend shown over the past year. In fact, it has been weak enough that the rate of expansion may accelerate in the coming months.
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to firstname.lastname@example.org.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.